A novel vaccine can mobilize the immune system to precisely target and attack cancerous brain tumors, specifically gliomas, ...

Servier today announced that it will present data at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO), ...

By converting immunologically 'cold' tumours into 'hot' ones, MB-108 may enhance the efficacy of the MB-101 CAR-T cell ...

“RANO 2.0 is a recently established response assessment criteria for gliomas that supersedes prior versions such as RANO-HGG and RANO-LGG. RANO 2.0 incorporates an integrated quantitative assessment ...

For the treatment of glioblastoma, immunotherapy represents a promising, though complex, avenue. Due to the tumour’s highly ...

The following is a summary of “Integrated analysis of bulk and single-cell RNA sequencing reveals the impact of nicotinamide ...

Genetic disorders include conditions like cystic fibrosis and Duchenne muscular dystrophy, while rare cancers like ...

Multiple studies show the benefits of organic food, including lower risks of some cancers, obesity and congenital ...

Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in ...

Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade ...